MDMA Effects in Brain: Pharmacologic Profile and Evidence of Neurotoxicity from Neurochemical and Autoradiographic Studies

1990 ◽  
pp. 171-199 ◽  
Author(s):  
George Battaglia ◽  
Robert Zaczek ◽  
Errol B. De Souza
Keyword(s):  
Pharmacologic Profile

Pharmacologic profile of chemically stable analogs of peptide leukotrienes

1987 ◽  
Vol 138 (3) ◽  
pp. 397-405 ◽  
Author(s):  
David W. Snyder ◽  
Peter R. Bernstein
Keyword(s):  
Pharmacologic Profile

Pharmacologic profile of zoledronic acid: A highly potent inhibitor of bone resorption

2002 ◽  
Vol 55 (4) ◽  
pp. 210-224 ◽  
Author(s):  
Jonathan R. Green ◽  
Michael J. Rogers
Keyword(s):  
Zoledronic Acid ◽  
Bone Resorption ◽  
Potent Inhibitor ◽  
Pharmacologic Profile

scholarly journals In Vivo Pharmacologic Profile of ONO-1078: A Potent, Selective and Orally Active Peptide Leukotriene (LT) Antagonist

1992 ◽  
Vol 60 (3) ◽  
pp. 217-225
Author(s):  
Nakagawa Naoki ◽  
Obata Takaaki ◽  
Kobayashi Tadamasa ◽  
Okada Yutaka ◽  
Nambu Fumio ◽  
...  
Keyword(s):  
Active Peptide ◽  
Orally Active ◽  
Pharmacologic Profile

The pharmacologic profile of desloratadine: a review

Allergy ◽  
2001 ◽  
Vol 56 (s65) ◽  
pp. 7-13 ◽  
Author(s):  
B. M. Henz
Keyword(s):  
Pharmacologic Profile

Suspected Neuroleptic Malignant Syndrome in a Patient Receiving Clozapine

1996 ◽  
Vol 30 (3) ◽  
pp. 248-250 ◽  
Author(s):  
Luba Ganelin ◽  
Pesach S Lichtenberg ◽  
Esther-Lee Marcus ◽  
R Gabriel Munter
Keyword(s):  
Creatine Kinase ◽  
Neuroleptic Malignant Syndrome ◽  
Supportive Therapy ◽  
Serum Creatine Kinase ◽  
Clozapine Therapy ◽  
Antipsychotic Medications ◽  
Case Summary ◽  
Pharmacologic Profile

OBJECTIVE: To report a case of suspected neuroleptic malignant syndrome (NMS) associated with clozapine therapy. CASE SUMMARY: A 42-year-old schizophrenic man treated with clozapine developed a temperature of 39.5 °C, diaphoresis, tachycardia, rigidity, and leukocytosis. His serum creatine kinase concentration was 25 000 U/L. A diagnosis of NMS was made. He was treated with bromocriptine and supportive therapy, and recovered within a week. DISCUSSION: Despite earlier expectations that clozapine, with a pharmacologic profile differing from that of other antipsychotic medications, might not cause NMS, NMS remains the most likely diagnosis in this case. CONCLUSIONS: NMS may be a possible complication of clozapine therapy.

Low-molecular-weight heparins: pharmacologic profile and product differentiation

1998 ◽  
Vol 82 (5) ◽  
pp. 3L-10L ◽  
Author(s):  
Jawed Fareed ◽  
Walter Jeske ◽  
Debra Hoppensteadt ◽  
Rana Clarizio ◽  
Jeanine M. Walenga
Keyword(s):  
Molecular Weight ◽  
Product Differentiation ◽  
Low Molecular Weight ◽  
Low Molecular Weight Heparins ◽  
Pharmacologic Profile
Sign in / Sign up

Export Citation Format

Share Document